Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency — Stella

Home/Mevalonate Kinase Deficiency/

View on ClinicalTrials.gov

Recruiting

Back to Mevalonate Kinase Deficiency trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Czechia

University Hospital, Motol, Prague

Key details

Sponsor

University Hospital, Motol

Collaborators

Washington University School of Medicine

Enrollment target

~6 participants

Started

January 2022

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

12 Years and older

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.